Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KOD |
---|---|---|
09:32 ET | 5615 | 2.56 |
09:39 ET | 100 | 2.56 |
09:41 ET | 100 | 2.56 |
09:43 ET | 100 | 2.565 |
09:45 ET | 1200 | 2.52 |
09:48 ET | 500 | 2.55 |
09:50 ET | 400 | 2.52 |
09:54 ET | 951 | 2.54 |
09:56 ET | 2309 | 2.5203 |
09:57 ET | 300 | 2.525 |
09:59 ET | 4000 | 2.54 |
10:01 ET | 800 | 2.525 |
10:06 ET | 1700 | 2.535 |
10:08 ET | 1023 | 2.55 |
10:10 ET | 300 | 2.535 |
10:12 ET | 3200 | 2.55 |
10:14 ET | 200 | 2.55 |
10:17 ET | 3628 | 2.55 |
10:19 ET | 958 | 2.55 |
10:21 ET | 100 | 2.555 |
10:24 ET | 390 | 2.555 |
10:26 ET | 698 | 2.57 |
10:30 ET | 1540 | 2.57 |
10:33 ET | 100 | 2.55 |
10:35 ET | 860 | 2.555 |
10:37 ET | 300 | 2.56 |
10:42 ET | 400 | 2.59 |
10:46 ET | 500 | 2.575 |
10:48 ET | 2355 | 2.59 |
10:51 ET | 3067 | 2.6 |
10:53 ET | 700 | 2.605 |
10:57 ET | 260 | 2.605 |
11:00 ET | 100 | 2.6 |
11:04 ET | 100 | 2.6 |
11:06 ET | 1976 | 2.57 |
11:09 ET | 200 | 2.555 |
11:11 ET | 100 | 2.55 |
11:13 ET | 700 | 2.56 |
11:20 ET | 100 | 2.56 |
11:26 ET | 4903 | 2.6 |
11:27 ET | 13839 | 2.605 |
11:29 ET | 200 | 2.605 |
11:31 ET | 100 | 2.6 |
11:36 ET | 100 | 2.6 |
11:40 ET | 200 | 2.605 |
11:42 ET | 524 | 2.6 |
11:45 ET | 1149 | 2.615 |
11:47 ET | 200 | 2.61 |
11:49 ET | 6366 | 2.6 |
11:58 ET | 105 | 2.6 |
12:00 ET | 5534 | 2.615 |
12:02 ET | 200 | 2.61 |
12:03 ET | 4065 | 2.6 |
12:05 ET | 100 | 2.6 |
12:07 ET | 200 | 2.6 |
12:09 ET | 380 | 2.6 |
12:12 ET | 300 | 2.6 |
12:16 ET | 100 | 2.6 |
12:21 ET | 700 | 2.6 |
12:25 ET | 100 | 2.605 |
12:30 ET | 199 | 2.605 |
12:32 ET | 569 | 2.6059 |
12:34 ET | 300 | 2.6 |
12:36 ET | 7099 | 2.611 |
12:38 ET | 200 | 2.615 |
12:41 ET | 500 | 2.61 |
12:43 ET | 300 | 2.605 |
12:45 ET | 2526 | 2.59 |
12:50 ET | 100 | 2.575 |
12:57 ET | 100 | 2.58 |
01:01 ET | 600 | 2.56 |
01:06 ET | 300 | 2.56 |
01:08 ET | 900 | 2.56 |
01:10 ET | 200 | 2.555 |
01:12 ET | 100 | 2.56 |
01:14 ET | 700 | 2.565 |
01:15 ET | 1500 | 2.56 |
01:17 ET | 400 | 2.56 |
01:21 ET | 100 | 2.55 |
01:24 ET | 200 | 2.545 |
01:26 ET | 2929 | 2.55 |
01:28 ET | 200 | 2.55 |
01:33 ET | 200 | 2.57 |
01:35 ET | 100 | 2.57 |
01:37 ET | 100 | 2.56 |
01:42 ET | 200 | 2.56 |
01:44 ET | 1701 | 2.58 |
01:48 ET | 499 | 2.58 |
01:51 ET | 200 | 2.575 |
01:53 ET | 2209 | 2.585 |
01:57 ET | 100 | 2.585 |
02:00 ET | 212 | 2.59 |
02:02 ET | 100 | 2.595 |
02:06 ET | 1133 | 2.61 |
02:08 ET | 300 | 2.61 |
02:09 ET | 100 | 2.605 |
02:11 ET | 100 | 2.605 |
02:13 ET | 200 | 2.61 |
02:15 ET | 5220 | 2.625 |
02:18 ET | 1382 | 2.61 |
02:20 ET | 626 | 2.6 |
02:22 ET | 1511 | 2.575 |
02:24 ET | 1552 | 2.6 |
02:29 ET | 100 | 2.605 |
02:31 ET | 100 | 2.605 |
02:33 ET | 200 | 2.61 |
02:36 ET | 600 | 2.605 |
02:38 ET | 1200 | 2.605 |
02:42 ET | 1900 | 2.6 |
02:44 ET | 1600 | 2.605 |
02:51 ET | 100 | 2.605 |
02:54 ET | 200 | 2.6 |
02:58 ET | 100 | 2.6 |
03:00 ET | 600 | 2.6 |
03:02 ET | 200 | 2.6 |
03:03 ET | 300 | 2.59 |
03:05 ET | 400 | 2.595 |
03:09 ET | 200 | 2.6 |
03:12 ET | 100 | 2.605 |
03:14 ET | 100 | 2.605 |
03:16 ET | 1620 | 2.59 |
03:18 ET | 100 | 2.59 |
03:20 ET | 766 | 2.6 |
03:21 ET | 600 | 2.6 |
03:23 ET | 100 | 2.595 |
03:25 ET | 200 | 2.6 |
03:27 ET | 100 | 2.605 |
03:30 ET | 100 | 2.605 |
03:32 ET | 1919 | 2.595 |
03:34 ET | 100 | 2.6 |
03:36 ET | 698 | 2.62 |
03:38 ET | 1442 | 2.6 |
03:39 ET | 200 | 2.595 |
03:41 ET | 405 | 2.6 |
03:43 ET | 100 | 2.605 |
03:45 ET | 200 | 2.605 |
03:48 ET | 4766 | 2.59 |
03:50 ET | 200 | 2.595 |
03:52 ET | 1844 | 2.6 |
03:54 ET | 1905 | 2.595 |
03:56 ET | 300 | 2.6 |
03:57 ET | 847 | 2.605 |
03:59 ET | 54225 | 2.6 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kodiak Sciences Inc | 137.3M | -0.7x | --- |
Vigil Neuroscience Inc | 134.8M | -1.6x | --- |
PDS Biotechnology Corp | 140.7M | -3.0x | --- |
aTyr Pharma Inc | 133.4M | -1.9x | --- |
Actuate Therapeutics Inc | 145.5M | 0.0x | --- |
Context Therapeutics Inc | 147.0M | -1.8x | --- |
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $137.3M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.34 |
EPS | $-3.77 |
Book Value | $5.06 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.